Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.38 |
| ▸ | KDM4A | O75164 | 1/20 | 0.38 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.38 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20530387 | 1.00 | LMNA (0.67) | LMNATRPV1TRPA1KDM4CKDM4A | |
| SCHEMBL21925059 | 1.00 | LMNA (0.67) | LMNATRPV1TRPA1KDM4CKDM4A | |
| SCHEMBL16097135 | 1.00 | LMNA (0.67) | LMNATRPV1TRPA1KDM4CKDM4A | |
| SCHEMBL7580335 | 1.00 | LMNA (0.67) | LMNATRPV1TRPA1KDM4CKDM4A | |
| SCHEMBL11723029 | 1.00 | LMNA (0.67) | LMNATRPV1TRPA1KDM4CKDM4A | |
| SCHEMBL104886 | 1.00 | LMNA (0.67) | LMNATRPV1TRPA1KDM4CKDM4A | |
| SCHEMBL11207754 | 1.00 | LMNA (0.67) | LMNATRPV1TRPA1KDM4CKDM4A | |
| SCHEMBL108076 | 0.95 | LMNA (0.71) | LMNATRPV1TRPA1KDM4CKDM4A | |
| Water SCHEMBL4955769 | 0.91 | LMNA (0.67) | LMNATRPV1TRPA1KDM4CKDM4A | |
| SCHEMBL42290 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260081215-A1 | SOLID STATE BATTERIES AND METHODS OF MAKING THEREOF | LG ENERGY SOLUTION LTD (KR) | 2026-03-19 | — | — | US | claimed |
| US-20260005296-A1 | SOLID STATE BATTERIES AND METHODS OF MAKING THEREOF | LG ENERGY SOLUTION LTD (KR) | 2026-01-01 | — | — | US | claimed |
| US-12512509-B2 | Solid state batteries and methods of making thereof | LG ENERGY SOLUTION, LTD. (KR) | 2025-12-30 | — | — | US | claimed |
| US-12438188-B2 | Solid state batteries and methods of making thereof | LG ENERGY SOLUTION, LTD. (KR) | 2025-10-07 | — | — | US | claimed |
| US-20250266494-A1 | SOLID STATE BATTERIES AND METHODS OF MAKING THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-08-21 | — | — | US | claimed |
| US-20250266495-A1 | SOLID STATE BATTERIES AND METHODS OF MAKING THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-08-21 | — | — | US | claimed |
| CN-120058495-A | Process for the preparation of mixed alkyl ketones and alkyl alcohols | 武汉希音新材料科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-118993844-A | Process for the preparation of mixed alkyl ketones and alkyl alcohols | 武汉希音新材料科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-110229192-B | Deuterated iridium complex and preparation method and application thereof | 南京佳诺霖光电科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-109072129-A | Cleaning agent composition | 花王株式会社 | 2018-12-21 | — | — | CN | claimed |
| EP-2463374-A2 | Isolated alcohol dehydrogenase enzymes and uses thereof | Bio Architecture Lab, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| US-20260081215-A1 | SOLID STATE BATTERIES AND METHODS OF MAKING THEREOF | LG ENERGY SOLUTION LTD (KR) | 2026-03-19 | — | — | US | disclosed |
| US-20260005296-A1 | SOLID STATE BATTERIES AND METHODS OF MAKING THEREOF | LG ENERGY SOLUTION LTD (KR) | 2026-01-01 | — | — | US | disclosed |
| US-4699923-A | N-benzoyl-N'-phenylureas and their use for insect control | BASF AKTIENGESELLSCHAFT (DE) | 1987-10-13 | — | — | US | disclosed |
| US-4599356-A | N-benzoyl-N'-phenylureas and their use for insect control | BASF AKTIENGESELLSCHAFT (DE) | 1986-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260005296-A1 | SOLID STATE BATTERIES AND METHODS OF MAKING THEREOF | KCNN3, KCNN2, KCNN1 | LMNA 1811/4885TRPV1 1364/4885TRPA1 383/4885 |
| US-12512509-B2 | Solid state batteries and methods of making thereof | SCO2, SF3B3, SF3B2 | LMNA 1865/4885TRPV1 1348/4885TRPA1 97/4885 |
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | LMNA 3717/4885TRPV1 3969/4885TRPA1 3765/4885 |
| US-20260081215-A1 | SOLID STATE BATTERIES AND METHODS OF MAKING THEREOF | KCNN3, KCNN2, KCNN1 | LMNA 1745/4885TRPV1 1196/4885TRPA1 285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.